229 related articles for article (PubMed ID: 330440)
21. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
Cording-Tömmel C; von Zerssen D
Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
[TBL] [Abstract][Full Text] [Related]
22. Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
Singh AN; Saxena B; Gent M; Nelson HL
Curr Ther Res Clin Exp; 1976 Apr; 19(4):451-62. PubMed ID: 816603
[No Abstract] [Full Text] [Related]
23. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
Schmauss M; Laakmann G; Dieterle D; Blaschke D
Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
[TBL] [Abstract][Full Text] [Related]
24. A comparison of maprotiline (Ludiomil) and amitriptyline (2).
Mindham BA
J Int Med Res; 1977; 5 Suppl 4():25-33. PubMed ID: 338399
[TBL] [Abstract][Full Text] [Related]
25. [A double-blind comparison between mianserin and imipramine (author's transl)].
Pull CB; Pichot P; Dreyfus JF
Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
[TBL] [Abstract][Full Text] [Related]
26. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
27. A comparison of maprotiline (Ludiomil) and amitriptyline (1).
Dell AJ
J Int Med Res; 1977; 5 Suppl 4():22-4. PubMed ID: 338398
[TBL] [Abstract][Full Text] [Related]
28. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Fabre LF
J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
[TBL] [Abstract][Full Text] [Related]
29. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
30. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Poelinger W; Haber H
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
[No Abstract] [Full Text] [Related]
31. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
32. A controlled double-blind clinical trial between maprotiline and amitriptyline in depressive illness.
Okasha A; Sadek A
J Egypt Med Assoc; 1976; 59(5-6):557-62. PubMed ID: 801741
[No Abstract] [Full Text] [Related]
33. A double-blind comparison of once-daily flupenthixol and mianserin in depressed hospital out-patients.
Majid I
Pharmatherapeutica; 1986; 4(7):405-10. PubMed ID: 3515368
[TBL] [Abstract][Full Text] [Related]
34. A double-blind multicentre trial comparing mianserin with imipramine.
Pichot P; Dreyfus JF; Pull C
Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):87S-90S. PubMed ID: 341950
[TBL] [Abstract][Full Text] [Related]
35. Intraindividual comparison of the antidepressant effectivity of viloxazine and maprotiline.
Dostal T; Kabes J
Act Nerv Super (Praha); 1978 Dec; 20(4):252-3. PubMed ID: 735720
[No Abstract] [Full Text] [Related]
36. [Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
Zapletálek M; Hübsch T; Zbytovský J; Polácková J; Kindernayovä H
Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):323-34. PubMed ID: 333568
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
[TBL] [Abstract][Full Text] [Related]
38. Treatment of major depression in general practice: a double-blind comparison of paroxetine and lofepramine.
Moon CA; Vince M
Br J Clin Pract; 1996; 50(5):240-4. PubMed ID: 8794599
[TBL] [Abstract][Full Text] [Related]
39. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
40. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
